Ambea completes Humana takeover after reaching 90.84% acceptance level

• Ambea completed its offer for Humana, securing acceptances for 43,166,701 shares, equal to 90.84% of shares and votes.
• Offer declared unconditional; acceptance period extended to Oct. 14, 2026, with settlement for initial tenders expected around Oct. 8.
• Consideration includes cash, shares in Ambea, and CVR Instruments; settlement for extended-period tenders expected around Oct. 21.
• To deliver share consideration, Ambea transferred 5,560,658 treasury shares, issued 7,605,186 new shares, lifting total shares to 87,989,610.
• The issuance increased share capital by SEK 225,638.263434, implying about 8.6% dilution; Humana delisting planned alongside a squeeze-out.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ambea AB published the original content used to generate this news brief via Cision (Ref. ID: 20261001:BIT:8041:0) on October 01, 2026, and is solely responsible for the information contained therein.